Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: Corticosteroids in Hyperinflammatory Phenotype of Critical Illness Trial sites expanded: 1 → 11 locations
- Minor: BEACON-AA · Apixaban With or Without Clopidogrel in Stroke · Atrial Fibrillation and Cerebral Atherosclerosis Trial sites expanded: 0 → 21 locations
- Minor: Progressive Supranuclear Palsy Clinical Trial Platform Trial sites expanded: 21 → 24 locations
- Minor: Effective and Safe Odronextamab is Compared to Standard of Care · Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma Study completion moved earlier from May 29, 2029 to May 29, 2028
- Minor: Guselkumab Subcutaneous Therapy · Moderately to Severely Active Crohn's Disease Study completion moved earlier from Oct 30, 2028 to Mar 27, 2028
- Minor: ORJ-001 · IPF Start date pushed from Oct 2026 to Nov 2026
- Minor: SPY072 · Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial) Start date changed from estimate of Sep 2026 to Oct 6, 2026
- Minor: National Registry of Noonan Syndrome Trial sites reduced: 35 → 13 locations
- Minor: Food Effect of UBT48128 Tablets in Healthy Participants Study completion pushed from Dec 30, 2026 to Mar 31, 2027
- Minor: Dietary Supplement Effect on Improvement of Hair Condition · Occasional Hair Loss Start date pushed from Oct 2026 to Nov 2026
- Minor: Methoxyamine, Cisplatin, and Pemetrexed Disodium · Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin Study completion pushed from Oct 15, 2026 to Oct 15, 2027
- Minor: Radiation Therapy With or Without Chemotherapy · High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery Study completion moved earlier from Dec 31, 2031 to Sep 30, 2031
- Minor: GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial Final enrollment: 33 participants (planned 30)
- Minor: Adding IL-2 to Tebentafusp to Eradicate Cancer Progression Study completion pushed from Sep 2027 to Sep 1, 2028
- Minor: MVA-BN · HIV for the Prevention of Mpox Infection, in Kinshasa, DRC Study completion pushed from Nov 30, 2026 to Dec 31, 2026
- Minor: Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction Study completion pushed from Oct 30, 2026 to Dec 30, 2026
- Minor: Natalizumab · ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell Therapy Start date changed from estimate of Nov 1, 2026 to Nov 10, 2026
- Minor: Impact of AHCC® Supplementation · Respiratory Tract Infections Among Children Age 4-6 Years Old Interventions modified
- Minor: Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response Primary completion date changed from estimate of Jun 2026 to Oct 30, 2026
- Minor: Skin Changes From the Use of Moisturizers · Cancer Experiencing Dermatological Adverse Events Start date pushed from Oct 2026 to Nov 2026
- Minor: Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception Study completion pushed from Sep 30, 2026 to Dec 31, 2026
- Minor: Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders Study completion pushed from Dec 2026 to May 2027
- Minor: Sports Based Structured Cognitive Therapy Program on Attention, Memory and Behavior for School Going Children Study completion pushed from Oct 30, 2026 to Jan 30, 2027
- Minor: Performance, Shade Matching, and Patient Satisfaction of Different Resin Composite Layering Techniques Using 3D Printed Cast Study completion moved earlier from Dec 27, 2026 to Nov 20, 2026
- Minor: Use of Respiratory Quotient ''RQ'' Improve Treatment Outcomes for Intensive Care Unit (ICU) Patients? Study completion pushed from Oct 31, 2027 to Dec 31, 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates